Liberty Global helped the MathCapital and Here-backed customer intelligence software provider take its series C funding to $71.5m.

MassMutual Ventures and Advance Venture Partners returned to back the relationship management tool provider’s latest round, which brought its overall funding to $120m.

Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.

HomeLane has now taken in over $104m of funding since it was founded, including a series E round backed by Pidilite Group.

Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.

Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.

Illumina’s corporate venturing unit took part in a round that brought the proteomic platform developer’s overall funding to $110m.

Dell, Hewlett Packard, Relx and Alphabet helped boost the database technology provider’s total funding to $264m.

SR One Capital Management has led the RNA targeting drug developer’s latest round, participating alongside investors including Lilly Asia Ventures.

The Aviva and Foxconn-backed respiratory system developer beat the target for its series D round to bring its total funding to over $150m.